相关实验视频

Updated: Dec 6, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

通过联盟方法揭示瘤表皮质免疫性关键参数改善新抗原预测

Daniel K Wells¹, Marit M van Buuren², Kristen K Dang³

¹Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.

|October 10, 2020

概括

研究人员开发了一个新的模型来预测免疫性瘤表位, 过出98%的非免疫性. 这种新抗原的发现有助于理解抗瘤免疫力.

科学领域:

免疫学
生物信息学
癌症学

背景情况:

鉴定具有治疗意义的新抗原对于癌症免疫治疗至关重要.
目前的方法依赖于瘤测序和生物信息学,但缺乏表位免疫性标准化的参考数据.
控制瘤表皮质免疫性的参数仍然不完全理解.

研究的目的:

开发和验证瘤表位免疫性预测模型.
为比较新抗原预测方法建立参考数据集.
确定推动有效抗瘤免疫力的关键特征.

主要方法:

一个全球联盟从共享的瘤测序数据中预测了免疫性表位.
在与患者匹配的样本中评估了608个预测的T细胞结合.
通过整合与呈现和识别相关的特征开发了一个预测模型,并在一个独立的队列上进行了验证.

主要成果:

开发的模型成功过了98%的非免疫性,精度高于0.70.
优先考虑模型特征的管道在表位预测方面表现出卓越的表现.
在独立队列中的验证证实了该模型的预测准确性.

结论:

这项研究提供了一个可靠的模型来预测瘤表位免疫性,显著改善了新抗原的识别.
开发的数据资源和模型可以更深入地了解抗瘤免疫参数.
这项工作为研究界提供了有价值的工具,以推进癌症免疫治疗策略.

关键词:

泰斯拉公司标志物免疫性免疫遗传学免疫疗法新抗原

更多相关视频

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.